10.21147/j.issn.1000-9604.2019.05.05
First-line pemetrexed-platinum doublet chemotherapy with or without bevacizumab in non-squamous non-small cell lung cancer: A real-world propensity score-matched study in China
31
Wu Jieping Fund 320.6750.14266
2019-12-09(万方平台首次上网日期,不代表论文的发表时间)
共10页
749-758